Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Phase Ib Study of Z-213 in Subjects With Iron-deficiency Anemia - To Investigate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics -"

NCT02170311 is registered in ClinicalTrials.gov with Zeria Pharmaceutical as lead sponsor.

NCT NCT02170311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02170311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Phase Ib Study of Z-213 in Subjects With Iron-deficiency Anemia - To Investigate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics -"
Lead sponsor
Zeria Pharmaceutical
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2014
Completion date
March 31, 2015
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency anemia